PATENT CLAIM ANALYSIS

Application Number: 15759465
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
Improved distribution can be achieved by delivering nanoparticles possessing non-adhesive surfaces via CED in a hyperosmolar infusate solution. This delivery strategy minimizes the hindrances imposed by the brain extracellular matrix and reduces the concentration of therapeutic that is confined within perivascular spaces.

Claim (Index 14):
The formulation of  claim 13 , wherein the compositions are formulated for direct administration to the brain using convection enhanced delivery.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.1
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15310535', '15914796', '15310643', '13821320', '14726770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7374522593183825
- 35 USC 102 Novelty (BERT): 0.5124451298536066
- Combined Prediction Score: 0.7149515463719051
- Mean Citation Score: 245.921522
- Max Citation Score: 288.205
- Similarity Product: 208.2920063668489

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test